P719: RANDOMIZED PHASE 1‐2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW‐DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) PATIENTS: INTERIM SAFETY ANALYSIS.

Autor: Garcia‐Manero, Guillermo, Bachishvili, Kimo, A. Griffiths, Elizabeth, M. Zeidan, Amer, Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lübbert, Michael, Maness‐Harris, Lori, M Foran, James, Selleslag, Dominik, Xicoy Cirici, Blanca, Aaron Pollyea, Daniel, Sallman, David, Al‐Kali, Aref, Berdeja, Jesus, Kathrin Al‐Ali, Haifa, Y Zhu, Nancy, Font Lopez, Patricia
Zdroj: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Databáze: Complementary Index
Externí odkaz: